Go to Top
X

Media Room

  • AUTHENTIDATE HOLDING CORP. ANNOUNCES UPLISTING TO THE OTCQB TIER

    ANNOUNCES UPLISTING TO THE OTCQB TIER

    Gainesville, GA -August 17, 2017 –Authentidate Holding Corp. (OTCQB: ADAT), a growth oriented company focused on the development and provision of clinically actionable medical information and telemedicine services, announced today that its common stock has been approved for uplisting to the OTCQB market tier and will begin trading on the OTCQB market immediately.
    Read More
  • Aeon Global Health® Launches BDx Advantage™ - Extensive Blood Diagnostic Testing

    This new addition of blood testing offers clients a larger suite of services.

    GAINESVILLE, Ga., Feb. 23, 2017 /PRNewswire/ -- Authentidate Holding Corp. (OTC: ADAT), a provider of genetic hereditary cancer, molecular microbiology, pharmacogenomics, toxicology testing services, and secure, web-based software applications and telehealth products for healthcare organizations, today announced the addition of BDx Advantage™ Blood Diagnostic testing to their growing portfolio of
    Read More
  • Aeon Clinical Laboratories Launches MDx Advantage™ - an Innovative Women’s Health, qPCR-Based Diagnostic Test for STDs and Other Infections

    Expands genetic testing to include Molecular Microbiology, detecting multitude of organisms related to causes of bacterial vaginosis, candidiasis and STDs

    GAINESVILLE, Ga., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Authentidate Holding Corp. (ADAT), a provider of diagnostic services including toxicology and genetic testing, Telehealth, and web-based software applications for healthcare organizations, today announced the launch of an innovative new Women’s Health diagnostic test, MDx Advantage™, which utilizes Molecular Microbiology to improve on the legacy
    Read More
  • Aeon Participates in Groundbreaking Research on Drug Use by Pregnant Women

    Perinatal Analgesic Use: Influence of Psychiatric Morbidity

    Recent studies have demonstrated that up to 14% of women receive an opioid prescription during pregnancy. The majority of antepartum opioid exposure is not related to abuse, but could be influenced by psychiatric co-morbidity. The interaction between depression and pain during pregnancy has not been well examined.
    Read More
  • Aeon Global Health™ Adds 4 New Drug Classes and 17 New Medications to its Pharmacogenomics Test

    Expanded menu now covers over 200 medications and over 30 classes of drugs tested - making it one of the most extensive test menus on the market Enables physicians to offer their patients a personalized healthcare approach and to Prescribe with Confidence®

    Authentidate Holding Corp. (ADAT), through its wholly owned subsidiary, Aeon Global Health, which provides toxicology and genetic testing services and secure, web-based software applications and telehealth products for healthcare organizations, today announced it added 4 new drug classes and 17 new medications to its existing pharmacogenomics test.
    Read More
  • Authentidate’s Telehealth Solution Featured in Nephrology News & Issues®

    Authentidate Holding Corp. (Nasdaq: ADAT), a provider of web-based revenue cycle management applications and telehealth products and services for healthcare organizations was featured this month in an article in Nephrology News & Issues®, a publication that integrates the business and practice of quality kidney care.
    Read More
  • AEON Clinical Laboratory Partners with Authentidate’s HIPAA – Compliant Telehealth Platform for Houston Clinics

    Initial implementation of our telehealth-based mental health and rehab treatment in 8 clinics, which serve 80,000 patients annually

    Authentidate Holding Corp. (ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced the first cross-sold application of Authentidate’s leading telehealth solutions and AEON Clinical Laboratory’s leading clinical solutions.
    Read More
  • AEON and Authentidate Launch Cancer Genetic Testing With Telehealth-Based Genetic Counseling

    Cancer Detect Profile is Now Available for Use by More Than 6,000 Doctors to Reach More Than One Million Patients

    Authentidate Holding Corp. (Nasdaq:ADAT), has partnered with AEON Clinical Laboratories to nationally launch Cancer Detect Profile®, a 38-gene cancer genetic test coupled with telehealth-based genetic counseling for the prescribing physicians. The test is designed to identify patients with increased risk of colorectal, breast, pancreatic, ovarian, gastric, melanoma, stomach and other cancers.
    Read More